These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9766793)

  • 1. Effect of recombinant human erythropoietin treatment on circulating reticulated platelets in uremic patients: association with early improvement in platelet function.
    Tàssies D; Reverter JC; Cases A; Calls J; Escolar G; Ordinas A
    Am J Hematol; 1998 Oct; 59(2):105-9. PubMed ID: 9766793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of platelet functions, some hemostatic and fibrinolytic parameters in relation to serotonin in hemodialyzed patients under erythropoietin therapy.
    Malyszko J; Malyszko JS; Borawski J; Rydzewski A; Kalinowski M; Azzadin A; Mysliwiec M; Buczko W
    Thromb Res; 1995 Jan; 77(2):133-43. PubMed ID: 7740505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human erythropoietin treatment improves platelet function in uremic patients.
    Cases A; Escolar G; Reverter JC; Ordinas A; Lopez-Pedret J; Revert L; Castillo R
    Kidney Int; 1992 Sep; 42(3):668-72. PubMed ID: 1405344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin and uremic platelet aggregation in vivo and in vitro.
    Malyszko JS; Malyszko J; Pawlak K; Mysliwiec M
    Int J Clin Lab Res; 1996; 26(3):199-202. PubMed ID: 8905452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reticulated platelets in uremic patients: effect of hemodialysis and continuous ambulatory peritoneal dialysis.
    Tàssies D; Reverter JC; Cases A; Escolar G; Villamor N; López-Pedret J; Castillo R; Ordinas A
    Am J Hematol; 1995 Nov; 50(3):161-6. PubMed ID: 7485076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of platelet hyperfunction in hemodialysis patients receiving recombinant human erythropoietin.
    Zirkman DM; Zeigler ZR; Fraley DS; Bruns FJ; Adler S
    Am J Kidney Dis; 1993 Jan; 21(1):31-7. PubMed ID: 8418623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of uremic anemia with recombinant erythropoietin also reduces the defects in platelet adhesion and aggregation caused by uremic plasma.
    Zwaginga JJ; IJsseldijk MJ; de Groot PG; Kooistra M; Vos J; van Es A; Koomans HA; Struyvenberg A; Sixma JJ
    Thromb Haemost; 1991 Dec; 66(6):638-47. PubMed ID: 1665596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
    J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of erythropoietin on platelet serotonin storage and platelet aggregation in hemodialysis patients with reference to ketanserin treatment.
    Borawski J; Rydzewski A; Pawlak K; Azzadin A; Buczko W; Mysliwiec M
    Thromb Res; 1998 May; 90(4):171-80. PubMed ID: 9692616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human erythropoietin shortens the bleeding time and corrects the abnormal platelet aggregation in hemodialysis patients.
    el-Shahawy MA; Francis R; Akmal M; Massry SG
    Clin Nephrol; 1994 May; 41(5):308-13. PubMed ID: 8050212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel erythropoiesis stimulating protein exerts an effect on platelet function in uremia equivalent to that exerted by recombinant human erythropoietin.
    Fusté B; Escolar G; Cases A; López-Pedret J; Ordinas A; Díaz-Ricart M
    Haematologica; 2002 May; 87(5):551-3. PubMed ID: 12010672
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of platelet function during treatment with recombinant human erythropoietin (r-HuEPO) in patients hemodialyzed and dialyzed peritoneally].
    Janicka L; Majdan M; Dmoszyńska A; Ksiazek A; Berger B; Baranowska E
    Wiad Lek; 1993 Oct; 46(19-20):756-60. PubMed ID: 7975620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recombinant human erythropoietin and correction of anemia on platelet function in hemodialysis patients.
    Akizawa T; Kinugasa E; Kitaoka T; Koshikawa S
    Nephron; 1991; 58(4):400-6. PubMed ID: 1922603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the thrombopoietic status of patients on dialysis through the evaluation of megakaryocytopoiesis in bone marrow and of endogenous thrombopoietin levels.
    Ando M; Iwamoto Y; Suda A; Tsuchiya K; Nihei H
    Blood; 2001 Feb; 97(4):915-21. PubMed ID: 11159517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin does not increase whole-blood platelet aggregation in vitro.
    Taylor JE; Belch JJ; Henderson IS; Stewart WK
    Nephrol Dial Transplant; 1994; 9(5):556-8. PubMed ID: 8090338
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of the treatment with human recombinant erythropoietin on primary hemostasis in uremic patients].
    Cases A; Escolar G; Reverter JC; Garrido M; Ordinas A; López-Pedret J; Castillo R; Revert L
    Med Clin (Barc); 1990 Nov; 95(17):644-7. PubMed ID: 2089202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human erythropoietin increases platelet aggregation in chronic hemodialysis patients.
    Sayinalp N; Erdem Y; Ilhami Ozcebe O; Büyükaşik Y; Cağlar S; Dündar SV
    Thromb Res; 1998 May; 90(4):195-8. PubMed ID: 9692619
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant human erythropoietin increases blood pressure, platelet aggregability and platelet free calcium mobilisation in uraemic children: a possible link?
    Van Geet C; Van Damme-Lombaerts R; Vanrusselt M; de Mol A; Proesmans W; Vermylen J
    Thromb Haemost; 1990 Aug; 64(1):7-10. PubMed ID: 2274929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Platelet aggregation during the recombinant human erythropoietin (rHuEPO) treatment of patients with uremia].
    Mazerska M; Pawlak K; Azzadin A; Małyszko J; Małyszko J; Myśliwiec M; Buczko W
    Pol Arch Med Wewn; 1992 Oct; 88(4):230-7. PubMed ID: 1488323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of fibrinogen receptors and GPIIb molecules on uraemic platelets: effect of recombinant human erythropoietin therapy.
    Krzesłowska J; Rysz J; Cierniewski CS; Luciak M
    Nephrol Dial Transplant; 1995; 10(5):653-6. PubMed ID: 7566578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.